3M India Ltd
3M India is a subsidiary of 3M Company, USA. The Company manages its operations in four operating segments: Safety & Industrial , Transportation & Electronics, Health Care and Consumer. In India, the Company has manufacturing facilities at Ahmedabad, Bangalore, Pune and has a R&D Center in Bangalore.(Source : 202003 Annual Report Page No:137)
- Market Cap ₹ 31,527 Cr.
- Current Price ₹ 27,974
- High / Low ₹ 38,300 / 26,400
- Stock P/E 51.6
- Book Value ₹ 1,906
- Dividend Yield 0.58 %
- ROCE 40.5 %
- ROE 30.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 123%
- Company's working capital requirements have reduced from 30.7 days to 21.9 days
Cons
- Stock is trading at 14.8 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,840 | 2,140 | 2,363 | 2,710 | 3,017 | 2,987 | 2,605 | 3,336 | 3,959 | 4,189 | 4,186 | |
| Sales growth | +6% | +16% | +10% | +11% | -1% | -13% | +28% | +19% | +6% | +3% | |
| 1,636 | 1,803 | 1,994 | 2,211 | 2,481 | 2,537 | 2,345 | 2,947 | 3,355 | 3,430 | 3,396 | |
| Operating Profit | 204 | 337 | 369 | 499 | 536 | 450 | 259 | 389 | 604 | 759 | 791 |
| OPM % | 11% | 16% | 16% | 18% | 18% | 15% | 10% | 12% | 15% | 18% | 19% |
| 14 | 18 | 49 | 55 | 60 | 46 | 25 | 37 | 68 | 78 | 86 | |
| Interest | 4 | 2 | 2 | 2 | 1 | 4 | 2 | 4 | 7 | 3 | 5 |
| Depreciation | 50 | 49 | 47 | 44 | 44 | 59 | 62 | 55 | 58 | 53 | 53 |
| Profit before tax | 165 | 303 | 369 | 508 | 551 | 433 | 220 | 368 | 607 | 781 | 819 |
| Tax % | 34% | 36% | 35% | 34% | 33% | 26% | 26% | 26% | 26% | 25% | |
| 108 | 195 | 241 | 333 | 366 | 322 | 162 | 272 | 451 | 583 | 611 | |
| EPS in Rs | 96.17 | 172.89 | 213.72 | 295.91 | 325.06 | 285.99 | 144.14 | 241.43 | 400.37 | 517.90 | 542.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 237% | 132% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 17% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 53% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 2% |
| 3 Years: | -2% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 30% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 796 | 977 | 1,215 | 1,055 | 1,422 | 1,740 | 1,899 | 2,172 | 1,666 | 2,136 |
| 14 | 11 | 10 | 10 | 14 | 42 | 23 | 25 | 27 | 18 | |
| 306 | 430 | 695 | 1,234 | 672 | 578 | 718 | 798 | 1,010 | 1,083 | |
| Total Liabilities | 1,128 | 1,429 | 1,932 | 2,311 | 2,118 | 2,371 | 2,652 | 3,006 | 2,714 | 3,248 |
| 388 | 349 | 315 | 303 | 286 | 306 | 266 | 307 | 338 | 332 | |
| CWIP | 1 | 1 | 2 | 6 | 12 | 7 | 24 | 23 | 25 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 739 | 1,078 | 1,614 | 2,001 | 1,820 | 2,058 | 2,362 | 2,676 | 2,352 | 2,903 | |
| Total Assets | 1,128 | 1,429 | 1,932 | 2,311 | 2,118 | 2,371 | 2,652 | 3,006 | 2,714 | 3,248 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 177 | 261 | 365 | 36 | 253 | 245 | 321 | 327 | 465 | 643 | |
| -4 | 1 | 12 | 25 | -553 | 3 | -14 | -41 | -15 | -269 | |
| -119 | -5 | -4 | -2 | 3 | -25 | -25 | -21 | -980 | -128 | |
| Net Cash Flow | 54 | 257 | 373 | 59 | -297 | 223 | 282 | 265 | -530 | 246 |
| Free Cash Flow | 172 | 250 | 351 | 19 | 212 | 224 | 282 | 259 | 406 | 612 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 113% | 114% | 132% | 50% | 88% | 84% | 156% | 110% | 104% | 111% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 54 | 63 | 77 | 71 | 65 | 68 | 58 | 59 | 61 |
| Inventory Days | 101 | 89 | 92 | 96 | 94 | 92 | 104 | 85 | 91 | 77 |
| Days Payable | 53 | 69 | 111 | 93 | 81 | 66 | 114 | 94 | 113 | 120 |
| Cash Conversion Cycle | 97 | 74 | 44 | 79 | 84 | 92 | 58 | 49 | 36 | 19 |
| Working Capital Days | 57 | 39 | 16 | -26 | 54 | 63 | 54 | 38 | 32 | 22 |
| ROCE % | 21% | 34% | 33% | 44% | 27% | 12% | 18% | 31% | 41% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Permanent employees count ・Standalone data |
|
||||||||||
| R&D expenditure INR lakhs ・Standalone data |
|||||||||||
| Consumer segment revenue mix % of total revenue |
|||||||||||
| Health Care segment revenue mix % of total revenue |
|||||||||||
| Safety & Industrial segment revenue mix % of total revenue |
|||||||||||
| Transportation & Electronics segment revenue mix % of total revenue |
|||||||||||
| Customer Technical Center visitors count ・Standalone data |
|||||||||||
| Patents filed in India count ・Standalone data |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Copy of Newspaper publication on Q2 26-27 Financial Result
-
Announcement under Regulation 30 (LODR)-Change in Management
- 3M India approved Q2 FY26 results, appointed Chun Hao Lok, noted Elizabeth Kong’s resignation, and sought shareholder approval.
-
Board Meeting Outcome for Out Come Of Board Meeting
- 3M India approved Q2 FY26 results on Nov 6, 2026; appointed Chun Hao Lok, noted Elizabeth Kong's resignation.
-
Financial Results For Q2 26-27
- 3M India approved Q2/H1 FY27 results; appointed Chun Hao Lok and noted Elizabeth Kong's resignation.
-
Amendment Of The Agreements Executed In Relation To The Healthcare Business.
- 3M India amends healthcare agreements, gets US$13 million compensation, and extends distribution term by two years.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from nse
-
Annual Report 2013
from bse
Concalls
-
May 2026PPT
-
Mar 2026PPT
-
Jul 2024PPT
-
May 2024PPT
-
Jun 2023PPT
-
Jun 2023PPT
-
Jun 2022PPT
-
Feb 2022Transcript
-
Jun 2021Transcript
-
Mar 2021Transcript
-
Aug 2020Transcript
-
Mar 2020Transcript
-
Aug 2019Transcript
History of the company
3M is one of the world’s leading conglomerates with a presence in 70+ countries. 3M ventured into India as a part of their expansion strategy. Birla 3M India was incorporated in 1986 as a JV between the 3M group and the Birla group and later Y. Birla sold his stake and eventually the name of the company was changed to 3M India in 2002. [1] [2]
3M India benefits from the parent’s brands, patents, global product portfolio, technical knowledge, sourcing network and customer relationships but it is materially dependent on overseas group companies. In FY26:
- Purchases from group entities were ~₹1,358 crore, equivalent to 27% of revenue.
- Corporate management fees were ₹129 crore, Royalty paid to 3M Company was ₹87 crore.
- Related-party trade payables were ~₹458 crore.[3][4]